Cargando…
Japanese Society of Neuropsychopharmacology: “Guideline for Pharmacological Therapy of Schizophrenia”
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8411321/ https://www.ncbi.nlm.nih.gov/pubmed/34390232 http://dx.doi.org/10.1002/npr2.12193 |
Ejemplares similares
-
Japanese Society of Anxiety and Related Disorders/Japanese Society of Neuropsychopharmacology: Clinical practice guideline for social anxiety disorder (2021)
por: Asakura, Satoshi, et al.
Publicado: (2023) -
Practice guidelines for therapeutic drug monitoring of voriconazole: a consensus review of the Japanese Society of Chemotherapy and the Japanese Society of Therapeutic Drug Monitoring
por: Hamada, Yukihiro, et al.
Publicado: (2013) -
Pharmacological treatment algorithms for the acute phase, agitation, and maintenance phase of first‐episode schizophrenia: Japanese Society of Clinical Neuropsychopharmacology treatment algorithms
por: Takeuchi, Hiroyoshi, et al.
Publicado: (2021) -
Clinical Practice Guidelines for Hepatic Arterial Infusion Chemotherapy with a Port System Proposed by the Japanese Society of Interventional Radiology and Japanese Society of Implantable Port Assisted Treatment
por: Ueshima, Kazuomi, et al.
Publicado: (2022) -
Executive summary of the Clinical Guidelines of Pharmacotherapy for Neuropathic Pain: second edition by the Japanese Society of Pain Clinicians
por: Sumitani, Masahiko, et al.
Publicado: (2018)